Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08EOD
|
||||
Former ID |
DAP001253
|
||||
Drug Name |
Methsuximide
|
||||
Synonyms |
Celontin; Mesuximid; Mesuximida; Mesuximide; Mesuximidum; Methsuximid; Metosuccimmide; Metsuccimide; Petinutin; Methsuximide [BAN]; Metosuccimmide [DCIT]; PM 396; Alpha-Methylphensuximide; Celontin (TN); Mesuximida [INN-Spanish]; Mesuximide (INN); Mesuximidum [INN-Latin]; Methsuximide (USP); Petinutin (TN); Alpha-Methyl-alpha-phenyl N-methyl succinimide; N,2-Dimethyl-2-phenylsuccinimide; N-Methyl-alpha-methyl-alpha-phenylsuccinimide; (+-)-N,2-Dimethyl-2-phenylsuccinimide; (RS)-1,3-Dimethyl-3-phenyl-2,5-pyrrolidindion; 1,3-Dimethyl-3-phenyl-2,5-dioxopyrrolidine; 1,3-Dimethyl-3-phenyl-2,5-pyrrolidinedione; 1,3-Dimethyl-3-phenyl-pyrrolidin-2,5-dione; 1,3-Dimethyl-3-phenylsuccinimide; 1,3-dimethyl-3-phenylpyrrolidine-2,5-dione
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Anticonvulsants
|
||||
Company |
Pfizer Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C12H13NO2
|
||||
InChI |
InChI=1S/C12H13NO2/c1-12(9-6-4-3-5-7-9)8-10(14)13(2)11(12)15/h3-7H,8H2,1-2H3
|
||||
InChIKey |
AJXPJJZHWIXJCJ-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 77-41-8
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
7784245, 7847470, 7979936, 8154134, 10535562, 15171756, 29225451, 46505339, 48416252, 50048511, 57323472, 80615582, 92714623, 103193143, 104312168, 117476298, 121362356, 124899410, 126408324, 126629476, 126678061, 127417438, 134221929, 134338490, 134972484, 140288923, 144076268, 144207162, 144224652, 152101592, 160967839, 163118037, 164762136, 164762137, 175611120, 177513111, 178103802, 179225910, 204425454, 223366887, 223681174, 226421231, 241142344, 249582230, 249991606
|
||||
SuperDrug ATC ID |
N03AD03
|
||||
SuperDrug CAS ID |
cas=000077418
|
||||
Target and Pathway | |||||
Target(s) | Voltage-dependent T-type calcium channel alpha-1G subunit | Target Info | Blocker | [535283] | |
Pathway Interaction Database | Regulation of nuclear beta catenin signaling and target gene transcription | ||||
PathWhiz Pathway | Muscle/Heart Contraction | ||||
Reactome | NCAM1 interactions | ||||
References | |||||
Ref 538431 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 010596. | ||||
Ref 542243 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7228). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.